Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Humacyte

Biotech & Life Sciences · Durham, United States · Founded 2004 Unicorn

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$196M
Market cap · Apr/2026
Revenue
$2.0M
Latest reported FY

Investors

8 investors on Humacyte's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Global footprint

Where Humacyte has talent and traffic

Web traffic by country
12K monthly visits
across markets
🇺🇸 United States41.7%
🇨🇦 Canada20%
🇦🇺 Australia18.3%
🇪🇸 Spain9.2%
🇩🇪 Germany6.7%
Top 5 markets shown

Patent intelligence

$25M patent portfolio · 18 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value
$25M
12.9% of market cap · 16.1× smaller than top peer NovoCure ($409M)
18 active patent families
Where Humacyte innovates Biomedical engineeringTissue engineeredBiologyBioreactorStent
Below peer median on Strategic

Quality vs same-sector peers

Humacyte on the five Patsnap quality dimensions

Humacyte in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Humacyte concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Humacyte and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Humacyte on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.